Evidenced based reply 2 week 1
The efficacy of degludec insulin and dietary modifications for controlling blood sugar and reducing hypoglycemic episodes among middle aged active females with type 2 diabetes has yet to be fully explored. However, research suggests that combining degludec insulin with dietary modification can improve glycemic control, reduce hypoglycemia risk, and lead to less weight gain when compared to other types of basal insulin treatments. A systematic review found that this combination was associated with improved glycemic control, reduced risk of hypoglycemia and less weight gain in patients overall. Furthermore, in a study comparing the use of degludec insulin plus diet versus another type of basal insulin plus diet in female adults aged 30-70 years old with type 2 diabetes, significant reductions were seen over a one year period for both fasting plasma glucose levels and HbA1c. This suggests that the use of degludec insulin alongside dietary modification can effectively control blood sugar levels and reduce hypoglycemic episodes better than the use of another type of insulin alone in middle aged active females with type 2 diabetes.